Universe Pharmaceuticals (UPC) Assets Average (2021 - 2025)
Universe Pharmaceuticals' Assets Average history spans 5 years, with the latest figure at $68.6 billion for Q3 2025.
- On a quarterly basis, Assets Average rose 101.84% to $68.6 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $68.6 billion, a 101.84% increase, with the full-year FY2025 number at $68.6 billion, up 101.86% from a year prior.
- Assets Average hit $68.6 billion in Q3 2025 for Universe Pharmaceuticals, up from $34.0 billion in the prior quarter.
- Over the last five years, Assets Average for UPC hit a ceiling of $68.6 billion in Q3 2025 and a floor of $35.1 million in Q3 2021.
- Historically, Assets Average has averaged $12.9 billion across 5 years, with a median of $65.2 million in 2022.
- The widest YoY moves for Assets Average: up 60566.53% in 2024, down 29.83% in 2024.
- Tracing UPC's Assets Average over 5 years: stood at $35.1 million in 2021, then surged by 86.62% to $65.5 million in 2022, then dropped by 14.37% to $56.0 million in 2023, then surged by 60566.53% to $34.0 billion in 2024, then soared by 101.84% to $68.6 billion in 2025.
- Business Quant data shows Assets Average for UPC at $68.6 billion in Q3 2025, $34.0 billion in Q3 2024, and $45.6 million in Q1 2024.